About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key Studies Including KEYNOTE-590 & CheckMate 648"
By
Insights from 2024 ASCO® GI Annual Meeting
FEATURING
Richard Kim
,
Rutika Mehta
By
Insights from 2024 ASCO® GI Annual Meeting
FEATURING
Richard Kim
,
Rutika Mehta
0 views
January 29, 2024
Comments
0
Login to view comments.
Click here to Login
Featured Video
20:00
Exelixis
Child-Pugh Classification and its Role in Treatment Decisions in Pat…
Feat.
P. Gholam
Featured Video
10:25
Exelixis
Explore the mechanism of Action of a TKI in HCC
Feat.
W. Keiser
Recommended
AUTOPLAY
ON
Related
Newest
09:05
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancer…
Feat.
N. Uboha,
A. Turk,
K. Spencer,
M. Cecchini
27:12
Moffitt Cancer Center
Year in Review: Upper GI Cancers
Feat.
R. Kim,
R. Mehta
07:27
Jason Levy
Opus One: Final Results - RFA in Axial Skeleton
23:26
Yale Cancer Center
GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…
Feat.
C. Balch
09:58
Elizabeth Smyth
Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…
Feat.
R. Sundar
18:51
Hope for Stomach Cancer
1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…
Feat.
D. Catenacci
06:53
Insights from 2024 ASCO® GI Annual Meeting
ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implica…
Feat.
Y. Janjigian,
S. Cytryn,
S. Klempner
15:24
Horizon CME
MRD in GI Malignancies: Current Clinical Utility of ctDNA
Feat.
A. Scott
06:39
Oncology Data Advisor
Additional Advances in Esophagogastric Cancer Research and Clinical …
Feat.
J. Ajani
04:01
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tisleliz…
Feat.
H. Yoon
41:38
Dana-Farber Cancer Institute
Let Me Eat: The Road to Reconstructing the Esophagus
Feat.
J. Wee
15:47
Integrity CE
Resectable GEJ Adenocarcinoma: Case Presentation and Expert Panel Di…
Feat.
K. Bever,
R. Voong,
J. Hernandez,
S. Klempner
18:55
ImmunoTherapy Bridge 2023
Immunotherapy in GI Cancer: Current Treatment Landscape and Challeng…
Feat.
A. Avallone
11:02
ASCO GI 2023 Conference Coverage
ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…
Feat.
Y. Y. Janjigian
23:56
Scripps Health
Targeted Therapy Approaches for Upper GI Cancer
Feat.
M. Strickland
11:57
COR2ED The Heart of Medical Education
ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Ca…
Feat.
M. Socinski,
P. R. Galle,
S. Dawood,
E. Smyth,
S. Klempner
57:57
Hope for Stomach Cancer
1L Therapy for HER2+ Stage 4 Gastroesophageal Cancers
Feat.
D. Catenacci
19:29
Total Health
Case-Based Clinical Updates in GI Cancer: 56 y/o Male With GEJ Adeno…
Feat.
R. Mehta,
M. Tejani,
K. Blue
44:18
Debbie's Dream Foundation
ASCO® 2023 Insights: "What's New in Stomach and Esophageal…
Feat.
S. Klempner
23:39
OncoAlert
Year in Review: Gastric, Esophageal, & Liver Cancers
Feat.
S. Gill
